Response letter to the editor
Semin Arthritis Rheum. 2023 May 16:152223. doi: 10.1016/j.semarthrit.2023.152223. Online ahead of print. NO ABSTRACT PMID:37210284 DOI:10.1016/j.semarthrit.2023.152223
Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care units
Genome Med. 2021 Nov 17;13(1):182. doi: 10.1186/s13073-021-00991-y. ABSTRACT BACKGROUND: Clinical metagenomics (CMg) has the potential to be translated from a research tool into routine service
Clinical phenotypes of immediate first dose reactions to mRNA COVID-19: A multi-center latent class analysis
J Allergy Clin Immunol Pract. 2022 Sep 12:S2213-2198(22)00934-5. doi: 10.1016/j.jaip.2022.08.048. Online ahead of print. ABSTRACT BACKGROUND: Although immediate potentially allergic reactions have been reported after
Immunology of allergen immunotherapy
Immunother Adv. 2022 Nov 25;2(1):ltac022. doi: 10.1093/immadv/ltac022. eCollection 2022. NO ABSTRACT PMID:36530352 | PMC:PMC9749131 | DOI:10.1093/immadv/ltac022
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
Science. 2021 Aug 6;373(6555):642-648. doi: 10.1126/science.abi9745. Epub 2021 Jun 24. ABSTRACT Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the
Structural and functional characteristics of SARS-CoV-2 Omicron subvariant BA.2 spike
bioRxiv. 2022 Apr 28:2022.04.28.489772. doi: 10.1101/2022.04.28.489772. Preprint. ABSTRACT The Omicron subvariant BA.2 has become the dominant circulating strain of severe acute respiratory syndrome coronavirus 2